Oncology Based In-Vivo CRO Market Overview 2024: Size, Growth Drivers, and Major Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Oncology Based In-Vivo CRO Market for the Period 2024 to 2033?
The market size for oncology-based in-vivo CRO has seen considerable growth in recent times. The value of the market is predicted to surge from $1.27 billion in 2023 to $1.38 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 8.4%. Factors such as an increased emphasis on oncology treatments, a rising number of cancer incidences, a move towards personalized medicine, growth in the pharmaceutical industry, and a demand for target-specific therapies have all contributed to the growth evident in the historical period.
In the coming years, the oncology-focused in-vivo CRO market is predicted to experience significant expansion, scaling up to a market value of $2 billion by 2028 with a Compound Annual Growth Rate (CAGR) of 9.7%. This growth projection for the forecast period is largely attributed to the emergence of new market opportunities, the transition towards immuno-oncology therapies, a surge in oncology clinical trials, and the adoption of precision and targeted therapies. Predominant trends set to shape the forecast period include advancements in regenerative medicine and cell therapies, the need for accelerated drug development, the rise of digitalization and data analytics, a focus on tumor microenvironment, and the increased interest in biologics and immunotherapies.
Claim Your Free Sample of the Global Oncology Based In-Vivo CRO Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10521&type=smp
What Factors Are Responsible for the Growth of the oncology based in-vivo cro Market?
The escalation in cancer occurrences is anticipated to promote progress in the in-vivo CRO market focused on oncology. Cancer signifies a variety of disorders where abnormal cells proliferate unrestrainedly, breaching their usual limits, arise in virtually any organ or tissue and proliferate to other body parts via the blood and lymph systems. Innovative treatments and devices, necessitated by cancer diagnosis and treatment, are subjected to diverse preclinical tests, clinical tests, and regulatory procedures before they’re released in the market. An in-vivo CRO for oncology is engaged by a sponsor company to deliver research services like carrying out whole or partial phases of conducting a preclinical in-vivo investigation (tests or living beings like animals, plants, or whole cells) before the device or drug undergoes human trials. The surging cancer cases have also resulted in increased demand for innovative therapies and treatments, thus promoting the in-vivo CRO market for oncology. For instance, a journal published in 2021 by the American Chemical Society (ACS), a non-profit organization based in the US that supports chemistry-related scientific research, predicts that by 2040, the global cancer cases will reach 28.4 million, denoting a 47% increment from 2020. This spike in cancer prevalence is catalyzing the development of the oncology-based in-vivo CRO market.
Which Segments Are Important for Insight into the Oncology Based In-Vivo CRO Market?
1) By Indication: Blood Cancer, Solid Tumors, Other Indications
2) By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models
3) By Application: Hospitals, Rehabilitation Centers
What Are the Significant Trends Reshaping the Oncology Based In-Vivo CRO Sector?
Key players in the oncology-based in vivo CRO market are concentrating on creating innovative solutions to maintain their market standing. Crown Bioscience, a leading CRO for discovery, preclinical, and translational platforms and services, unveiled the 3D Ex Vivo Patient Tissue Platform in October 2021 to enhance the predictability of responses to immuno-oncology drug candidates. This system employs 3D models of fresh patient tumors and high-content imaging analysis to provide reliable drug response analysis, thereby aiding in the selection of candidates and the design of clinical programs. The platform uses patient tumor tissue obtained from biopsies, ascites, surgical resections, or pleural effusion samples, processed within a 24-hour span to maintain the tumor microenvironment. With the help of automated high-throughput platforms, high-content 3D imaging, and image analysis quantify the unique responses of individual cell populations in fresh patient tissues. The amalgamation of these results and analysis determines the impact of the drug or combination thereon on immune cell growth and tumor neutralization.
Order Now for Fast Delivery of Your Oncology Based In-Vivo CRO Market Report!
https://www.thebusinessresearchcompany.com/report/oncology-based-in-vivo-cro-global-market-report
Which Regions Are Essential for the Growth of the Oncology Based In-Vivo CRO Market?
North America was the largest region in the oncology based in-vivo CRO market in 2023. North America is expected to be the fastest-growing region in the global oncology-based in-vivo CRO market report during the forecast period. The regions covered in the oncology based in-vivo cro market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Oncology Based In-Vivo CRO Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oncology based in-vivo cro market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Oncology Based In-Vivo CRO Market Include
1. Oncology Based In-Vivo CRO Market Executive Summary
2. Oncology Based In-Vivo CRO Market Segments
3. Oncology Based In-Vivo CRO Market Size And Template Market Growth Rate
4. Key Oncology Based In-Vivo CRO Market Trends
5. Major Oncology Based In-Vivo CRO Market Drivers
……
25. Key Mergers And Acquisitions In The Oncology Based In-Vivo CRO Market
26. Top Oncology Based In-Vivo CRO Companies
27. Oncology Based In-Vivo CRO Market Opportunities And Strategies
28. Oncology Based In-Vivo CRO Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Optical Transport Network Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/optical-transport-network-global-market-report
Optical Instrument And Lens Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/optical-instrument-and-lens-global-market-report
Optical Communication and Networking Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
